Individuals Coming Off Slimming Medications Regain Weight Far More Rapidly Than Dieters

A recent study reveals that people who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who halt conventional lifestyle programs.

Findings released in a major health publication points out that while obese people frequently drop substantial amounts of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month once they quit.

"People buying these drugs need to be aware of the potential of quick rebound weight gain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery suggests a reversion to pre-treatment weight in about a year and a half.

Weighing Treatments

The analysis, which examined dozens of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.

Researchers point out that people who shed pounds through dieting usually see a more gradual creep back—perhaps 100 grams monthly—once they finish.

Understanding the Quick Rebound

Experts suggest the way of the drugs explains the accelerated weight return.

The injections mimic a natural hormone called GLP-1, which helps regulate appetite.

"Long-term administration of GLP-1 levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement leads to appetite is uncontrolled, making excessive eating far more likely."

A Lifelong Issue?

Health authorities advise the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Many experts contend that, given the likelihood of weight regain, the therapy is often life-long.

This perspective is reinforced by drug manufacturers, who say that the findings "underscore the persistent character of obesity," similar to managing conditions like diabetes.

User Accounts

Individuals who have come off the medication explain a powerful resurgence of appetite.

"It felt as if a switch flipping and you're instantly starving," recalled a patient.

This difficulty is compounded if patients have not adopted permanent dietary or behavioural changes during treatment.

Growing Adoption

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with interest remaining high.

• Adoption is greater among females compared to men.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the drugs through private prescriptions rather than the NHS.

In conclusion, experts stress that while GLP-1 drugs are potent tools for weight loss, they are not a standalone cure and long-term success hinges on ongoing lifestyle changes.